Inovio to Present DNA Medicine Research at Scientific Conferences

• Inovio will present DNA-based protein replacement therapeutics at the Soft Bones hypophosphatasia scientific meeting in New York on Nov. 8, 2026.
• It will present INO-D001 for hemophilia A at the World Federation of Hemophilia’s NTGT Workshop in Montreal on Nov. 12, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611021601PR_NEWS_USPR_____PH87086) on November 02, 2026, and is solely responsible for the information contained therein.